Safety and pharmacokinetics of atypical antipsychotics in children and adolescents

S Caccia - Pediatric Drugs, 2013 - Springer
Pediatric behavioral and affective disorders often require antipsychotic therapy, in
combination with psychotherapeutic interventions, for their treatment and stabilization …

Use of antipsychotic medications in pediatric populations: what do the data say?

RB Penfold, C Stewart, EM Hunkeler… - Current Psychiatry …, 2013 - Springer
Recent reports of antipsychotic medication use in pediatric populations describe large
increases in rates of use. Much interest in the increasing use has focused on potentially …

[HTML][HTML] The economic burden of fragile X syndrome: healthcare resource utilization in the United States

P Sacco, G Capkun-Niggli, X Zhang… - American health & drug …, 2013 - ncbi.nlm.nih.gov
Background Fragile X syndrome (FXS) is the most common inherited form of intellectual
disability with cognitive and behavioral impairments, and is associated with a lifetime of care …

[PDF][PDF] Use of quetiapine in child and adolescent populations–Response to letter from Dr Lambe

S Grigoriadis, EH Vonderporten… - Australian & New …, 2013 - academia.edu
We are grateful to be given an opportunity to comment on the letter by Dr Lambe (Lambe,
2013) in response to our previous correspondence (Monasterio and McKean, 2013), which …

[图书][B] A qualitative study of caregiver training in administration of psychotherapeutic medications to male foster children

VL Dahn - 2013 - search.proquest.com
Male foster children residing in higher levels of care were at least five times more likely to be
prescribed more than one psychotherapeutic medication concurrently compared to non …

[PDF][PDF] Pharmacologic treatment of acute agitation in the pediatric population: What to do when oral therapy is not an option

A Crispo, PDPGYP Resident - 2013 - Citeseer
Objectives:• Identify potential etiologies of acute agitation• Discuss the treatment options for
acute agitation• Distinguish the unique characteristics of the available intramuscular (IM) …

[HTML][HTML] Фармакотерапия расстройств аутистического спектра у детей: опыт зарубежных психофармакологов

ЛГ Бородина - Российский психиатрический журнал, 2013 - cyberleninka.ru
В настоящем обзоре представлены последние зарубежные данные по
фармакотерапии расстройств аутистического спектра (РАС). Приведены различные …

Monitoring bezpečnosti léčby risperidonem u dětí a adolescentů

I Drtílková - Psychiatrie pro praxi, 2013 - is.muni.cz
Risperidon je atypickým antipsychotikem velmi často užívaným u dětí. Byl potvrzen jeho
prospěch a bezpečnost v nízkých dávkách při léčbě poruch chování u dětí a adolescentů. Při …

Antipsychotic drugs and children: The good, the bad, and what to do about it.

C McKinney - 2013 - psycnet.apa.org
Despite the fact that the Food and Drug Administration has approved the use of
antipsychotic drugs for children in very few situations (ie, the use of risperidone for the …